Contra-indicated in patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes, or in patients with uncontrolled hypertension.
- TRADE NAME: Relpax (Pfizer)
- INDICATIONS: Migraine headaches
- CLASS: 5-HT1 agonist, Serotonin receptor agonist, Triptan
- HALF-LIFE: 4–5 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Clarithromycin, Dihydroergotamine, Itraconazole, Ketoconazole, Methysergide, Nefazodone, Nelfinavir, Paclitaxel, Ritonavir, SNRIs, SSRIs, Telithromycin, Triptans, Troleandomycin, Voriconazole
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
